Clinical Trials Logo

Clinical Trial Summary

The goal of this prospective, multi-centre, randomised controlled clinical study is to compare the diagnostic efficacy and safety of the three biopsy techniques (EBUS-TBNA, EBUS-TBCB, and EBUS-TBFB) in mediastinal/hilar lymph node biopsies. Participants will divided into EBUS-TBNA group, EBUS-TBCB group, and EBUS-TBFB group at a 1:1:1 ratio by using central, computerized random sequence, and then undertake EBUS-TBNA, EBUS-TBCB, or EBUS-TBFB according to the group. Researchers will compare the adequacy of sampling by the three biopsy techniques, their sample quality, diagnostic rate, and incidence of each adverse events.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06262620
Study type Interventional
Source China-Japan Friendship Hospital
Contact Gang Hou, MD
Phone 010-84205729
Email hougangcmu@163.com
Status Not yet recruiting
Phase N/A
Start date February 18, 2024
Completion date February 18, 2026